UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication

Scientific reports, 2022-01, Vol.12 (1), p.1449-1449, Article 1449

2022

Volltextzugriff (PDF)

Durable response without recurrence to Tolvaptan improves long-term survival

Journal of gastroenterology, 2020-12, Vol.55 (12), p.1150-1161

2020

Volltextzugriff (PDF)

Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C

Scientific reports, 2021-04, Vol.11 (1), p.9207-9207, Article 9207

2021

Volltextzugriff (PDF)

Overestimated renal function in patients with liver cirrhosis predicts poor prognosis

Hepatology research, 2022-07, Vol.52 (7), p.603-613

2022

Volltextzugriff (PDF)

Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals

Scientific reports, 2021-08, Vol.11 (1), p.16616-16616, Article 16616

2021

Volltextzugriff (PDF)

Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients

PloS one, 2022-07, Vol.17 (7), p.e0270786-e0270786

2022

Volltextzugriff (PDF)

The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease

Hepatology research, 2022-06, Vol.52 (6), p.508-521

2022

Volltextzugriff (PDF)

Time‐dependent changes in the seroprevalence of COVID‐19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID‐19

Hepatology research, 2020-10, Vol.50 (10), p.1196-1200

2020

Volltextzugriff (PDF)

Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma

PloS one, 2021-03, Vol.16 (3), p.e0247728-e0247728

2021

Volltextzugriff (PDF)

Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis

Journal of medical virology, 2023-02, Vol.95 (2), p.e28452-n/a

2023

Volltextzugriff (PDF)

Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy

Scientific reports, 2022-10, Vol.12 (1), p.16800-16800, Article 16800

2022

Volltextzugriff (PDF)

Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight

Hepatology research, 2023-07, Vol.53 (7), p.595-606

2023

Volltextzugriff (PDF)

Clarifying Privacy, Property, and Power: Case Study on Value Conflict Between Communities

Proceedings of the IEEE, 2019-03, Vol.107 (3), p.575-581

2019

Volltextzugriff (PDF)

Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon‐lambda 3 induction in chronic hepatitis B patients

Hepatology research, 2022-07, Vol.52 (7), p.586-596

2022

Volltextzugriff (PDF)

Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI

Cancers, 2021-07, Vol.13 (14), p.3633

2021

Volltextzugriff (PDF)

Frequency and Characteristics of Overestimated Renal Function in Japanese Patients with Chronic Liver Disease and Its Relation to Sarcopenia

Nutrients, 2021-07, Vol.13 (7), p.2415

2021

Volltextzugriff (PDF)

Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma

World journal of hepatology, 2022-07, Vol.14 (7), p.1480-1494

2022

Volltextzugriff (PDF)

Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma

Cancers, 2022-01, Vol.14 (1), p.232

2022

Volltextzugriff (PDF)

Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment

Liver cancer (Basel ), 2023-06, Vol.12 (2), p.156-170

2023

Volltextzugriff (PDF)

Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy

World journal of gastrointestinal oncology, 2021-12, Vol.13 (12), p.2076-2087

2021

Volltextzugriff (PDF)

Synthesis of Neoamphimedine

Heterocycles, 2012-04, Vol.85 (4), p.933

2012

Volltextzugriff (PDF)

Ecteinascidins 770 and 786 from the Thai Tunicate Ecteinascidia thurstoni

Journal of natural products (Washington, D.C.), 2002-06, Vol.65 (6), p.935-937

2002

Volltextzugriff (PDF)

Jorunnamycins A—C, New Stabilized Renieramycin-Type Bistetrahydroisoquinolines Isolated from the Thai Nudibranch Jorunna funebris

Chemical and Pharmaceutical Bulletin, 2007, Vol.55(1), pp.81-86

2007

Volltextzugriff (PDF)

1 – 25 von 417

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(326)
Mit Volltextzugriff
(372)

Publikationsform

Sprache

Englisch
(367)
Japanisch
(60)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication

Durable response without recurrence to Tolvaptan improves long-term survival

Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C

Overestimated renal function in patients with liver cirrhosis predicts poor prognosis

Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals

Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients

The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease

Time‐dependent changes in the seroprevalence of COVID‐19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID‐19

Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria

Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma

Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis

Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy

Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight

Clarifying Privacy, Property, and Power: Case Study on Value Conflict Between Communities

Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon‐lambda 3 induction in chronic hepatitis B patients

Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI

Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150

Frequency and Characteristics of Overestimated Renal Function in Japanese Patients with Chronic Liver Disease and Its Relation to Sarcopenia

Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma

Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma

Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment

Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy

Synthesis of Neoamphimedine

Ecteinascidins 770 and 786 from the Thai Tunicate Ecteinascidia thurstoni

Jorunnamycins A—C, New Stabilized Renieramycin-Type Bistetrahydroisoquinolines Isolated from the Thai Nudibranch Jorunna funebris

Suchergebnisse filtern